CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,500 target
Drug / intervention
biopsy +2 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00003302
NCT00003302N/ACompleted
CompareCT.gov

Breast MRI Protocol

Abramson Cancer Center at Penn Medicine·interventional·Posted Mar 1, 2004·Updated Sep 25, 2019

In Brief

A clinical study evaluating biopsy, magnetic resonance imaging, and 1 other intervention for Breast Cancer. Completed, enrolled 1,500 participants across 15 sites in 3 countries.

Detailed Summary

RATIONALE: New imaging procedures, such as MRI, may improve the ability to detect breast tumors. PURPOSE: Diagnostic study to determine the value of MRI in detecting breast tumors in women who have had suspicious mammographic or clinical examinations.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesCanada, Germany, United States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/ACompletedFinished
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 1, 2004
Enrollment StartMay 1, 1998
Primary CompletionJun 30, 2000
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 22.3 years ago

Interventions

biopsyprocedure

magnetic resonance imagingother

mammographyother